BACKGROUND: The aim of this study is to report a large series of patients (n = 1223) at risk of developing ovarian hyperstimulation syndrome (OHSS) who underwent coasting. METHODS: Coasting started when the leading follicle reached 16 mm and continued until the estradiol (E 2 ) level fell to 3000 pg/ml. RESULTS: The E 2 level at the start of coasting was (mean ± SD) 6408 ± 446 and it fell to 2755 ± 650 on the day of HCG injection, after (mean ± SD) 2.89 ± 0.94 days. The results were analysed according to the duration of coasting (Յ3 days, group I: n = 983; >3 days, group II: n = 240). The number of oocytes retrieved was (mean SD) 16.45 ± 6.25 and 14.93 ± 6.01 in groups I and II respectively (P < 0.05). The fertilization rates were 63 and 65% in groups I and II respectively (P > 0.05). The implantation and clinical pregnancy rates were 26 and 52% in group I compared to 18 and 36% in group II respectively (P < 0.05). Severe OHSS occurred in 16 cases, which represented 0.13% of all stimulated cycles, and 1.3% of patients who were at risk of developing OHSS. CONCLUSIONS: Our protocol of coasting was an effective measure in the prevention of OHSS, without jeopardizing the ICSI outcome. Coasting for >3 days is associated with a moderate decrease in the pregnancy rate.
Introduction
Since the beginning of our IVF programme in 1986, ovarian hyperstimulation syndrome (OHSS) has been the most serious and distressing complication to deal with. Unfortunately this serious complication occurred in 1.8% of our assisted reproductive technology cycles (Aboulghar et al., 1993) . The incidence in different centres was estimated to vary from 1 to 10% (Bornestein et al., 1989; Rizk and Smitz, 1992; Aboulghar et al., 1993; Serour et al., 1998) . Moreover, it occurs in a serious life-threatening form in 0.1-2% of assisted reproductive treatment cycles (Wheelan and Vlahos, 2000) . We have tried several methods for the prevention of OHSS (Aboulghar and Mansour, 2003) such as minimizing the dose of HMG (Golan et al., 1988; Macklon and Fauser, 2000; El-Sheikh et al., 2001) , reducing the dose of HCG for triggering ovulation (Abdalla et al., 1987) and giving intravenous albumin (Asch et al., 1993) ; however, complete prevention was never achieved. In 1995, we adopted the protocol of coasting (Sher et al., 1993 (Sher et al., , 1995 in our assisted reproductive technology programme and achieved a considerable reduction in the incidence of OHSS (Aboulghar et al., 2000) . Encouraged by our initial results we have been using coasting as a routine protocol in our assisted reproduction programme. In a recent survey by Delvigne and Rozenberg (2001) , it was found that coasting was the first choice as a preventive measure against OHSS. Unfortunately, so far no evidence-based uniform criteria have been established for the application of a definitive protocol for coasting (Delvigne and Rozenberg, 2002a ).
As we gained more experience with coasting, and the numbers of cycles became very large, we wished to report our experience using coasting with a detailed description of the protocol that reduced the incidence of OHSS. This is a retrospective analysis of a large series of patients at risk of developing severe OHSS who underwent coasting and were successfully managed to prevent the occurrence of OHSS without jeopardizing their chances of pregnancy. Analysis of the data was done to clarify when we stopped HMG and for how many days.
Materials and methods
The study included 1223 patients that underwent coasting between January 2000 and December 2004 at the Egyptian IVF-ET Center. The patients at risk of developing OHSS were informed that the coasting procedure would possibly prevent OHSS, but absolute prevention could not be guaranteed. Our internal review board approved the protocol of coasting. Controlled ovarian stimulation was performed using long GnRH agonist down-regulation protocol. GnRH agonist (Decapeptyl 0.1 mg) was given s.c. daily starting on day 20 of the cycle. After 2-3 weeks when the down-regulation was confirmed with estradiol (E 2 ) levels ≤50 pg/ml, HMG was started. Starting dose of HMG was 150-300 mIU per day, according to the patient's age and body weight, as well as the ovarian response in previous cycles. Monitoring was started on day 7 of HMG stimulation with daily E 2 measurements and vaginal ultrasonography. PCO patients and those with a previous history of OHSS were considered as having prior risk factors for developing OHSS. During the course of ovarian stimulation, patients were considered at actual risk of developing OHSS when they had: (i) large number of follicles (≥20) on both ovaries with the majority being small (<14 mm in mean diameter); (ii) estradiol level ≥3000 pg/ml.
When patients were considered at risk of developing OHSS, coasting protocol was applied as follows. When the leading follicle reached 16 mm in mean diameter, the HMG injections were stopped and GnRH agonist continued. Daily serum E 2 was estimated and HCG was given when serum E 2 fell to ≤3000 pg/ml. Ovum retrieval was performed 36 h after HCG administration. When we first started applying this protocol, before gaining enough experience, some patients (n = 86) were given HCG before the E 2 level fell to 3000 pg/ml.
Two embryologists simultaneously examined the follicular fluid to identify the oocyte-cumulus complexes (OCC). It should be noted that more time and attention was needed in order to identify OCC because of the diminished number of granulosa cells surrounding the oocytes in these cases. The OCC were transferred to tissue culture media and incubated until the time of insemination. Oocyte-denuding and ICSI was done as previously described (Mansour et al., 1996) . Embryo transfer was performed 48-72 h later replacing two or three embryos according to the patient's age and embryo quality. In some cases with previous IVF/ICSI failures, or patients aged ≥40 years, embryo transfer was done replacing four embryos. Serum βHCG was estimated 2 weeks after embryo transfer and ultrasound was scheduled 3 weeks later for positive cases. For ethical reasons we could not use a group of these patients as a control and expose them to the risk of developing OHSS. All data are presented as mean ± SD, unless otherwise stated.
Results
From January 2000 to December 2004, controlled ovarian stimulation was performed for 12 494 ICSI cycles at our centre. Coasting was done for 1223 patients who were diagnosed to be at risk of developing OHSS during that period. Their ages ranged between 18 and 45 years with a mean of 30.13 ± 4.65. The mean infertility period was 6.62 ± 4.10 years. Serum E 2 on the day of starting coasting, when the leading follicle reached 16 mm in diameter, was 6538 ± 2025 pg/ml. Serum E 2 on the day of HCG injection was 2755 ± 650 pg/ml. The number of coasting days ranged between 2 and 7 days with a mean of 2.89 ± 0.94. The mean number of oocytes retrieved, metaphase II (MII) oocytes, 2PN oocytes and embryos transferred were 16.21 ± 6.34, 12.76 ± 5.61, 8.11 ± 4.47 and 3.00 ± 0.69 respectively. The fertilization, implantation and clinical pregnancy rates were 63, 25 and 48% respectively ( Table I) .
The data were analysed according to the number of coasting days into two groups: group I (n = 983) when coasting was done for up to 3 days only, and group II (n = 240) when coasting was done for ≥4 days. There was no significant difference in the mean age, infertility period, HMG ampoules and E 2 level on day of HCG injection (Table I ). The numbers of oocytes retrieved and MII oocytes were significantly higher in group I as compared to group II. However, the fertilization rate was not significantly different (P = 0.06). The mean number of embryos transferred was not different. The implantation and clinical pregnancy rates were significantly higher in group I as compared to group II.
When we first started applying this protocol, before gaining enough experience, some patients (n = 86) were given HCG before the E 2 level fell to 3000 pg/ml. Their serum E 2 on the day of starting coasting and on the day of HCG injection was 6568 ± 2166 and 4817 ± 1268 pg/ml respectively.
Severe OHSS occurred in 16 patients, which is 0.13% (16/12 494) of stimulated cycles and 1.3% (16/1223) of patients at risk of developing OHSS, and these underwent coasting (data are shown in Table II ). It should be noted that all patients who developed OHSS were among the early cases to participate in this protocol and were given HCG before the E 2 level fellped to <3000 pg/ml. All 16 patients who developed severe OHSS had bilateral enlargements of the ovaries >10 cm and tense ascites. They complained of abdominal pain, dyspnoea, nausea and vomiting. In addition, one patient had severe vulval edema. Active management of these patients was performed using a combination of transvaginal ultrasound-guided aspiration of the ascitic fluid and intravenous fluids and albumin (Aboulghar et al., 1993) . Daily monitoring was done for urine output, haematocrit, serum electrolytes, creatinine, liver enzymes and albumin.
Analysis of the results was done to compare ICSI outcome with 3 coasting days to 4, 5, 6 and 7 days separately (Table III) . The numbers of cases undergoing coasting for 6 and 7 days was too small to be significant, 13 and 7 respectively. Coasting for 4 and 5 days significantly reduced the number of oocytes retrieved, MII oocytes, and the implantation and pregnancy rates. The more days of coasting, the more adverse effects on the results. Two cases of OHSS developed in our centre during this time that were not diagnosed as 'high risk' and did not undergo coasting.
Discussion
This study is a retrospective analysis of the results of coasting in a very large cohort of patients with threatening OHSS. The protocol used is to stop HMG when the leading follicle reaches 16 mm in mean diameter and then wait until E 2 falls to 3000 pg/ml before giving HCG. Using this protocol, the incidence of OHSS was very small (0.13% of all stimulated cycles and 1.3% of patients at risk of developing OHSS). Withholding HMG until E 2 level falls to a safe level before giving HCG, known as 'coasting', was first introduced for non-IVF cycles by Rabinovici et al. (1987) . The authors stopped HMG for 2-10 days to rescue 12 cycles that were at risk of OHSS. This idea was also applied in an attempt to avoid cancellation of 40 cycles in PCO patients with impending OHSS (Urman et al., 1992) . The authors withheld gonadotrophins and followed the patients by daily E 2 and ultrasound. After a drift period of 2.8 days, HCG was given and only one patient developed OHSS. The idea of coasting in IVF cycles was advocated by Sher et al. (1993 Sher et al. ( , 1995 when they withheld gonadotrophins between 4 and 9 days in 68 patients until E 2 levels fell to <3000 pg/ml. In their work they produced 27 viable pregnancies and none of the patients developed severe OHSS. Another study reported coasting in 66 patients at risk of developing OHSS, but only four patients developed OHSS (Ben-Nun et al., 1993) .
Coasting is widely used by many IVF centres and a number of publications have appeared in the literature, demonstrating that coasting was effective in reducing OHSS Awonuga et al., 1997; Dhont et al., 1998; Lee et al., 1998; Waldenstrom et al., 1999; Aboulghar et al., 2000; Ohata et al., 2000; Al-Shawaf et al., 2001 , 2002 Egbase et al., 2002) .
Despite the large number of studies available in the literature about coasting, there are no definite criteria for a specific protocol on how to apply it (Delvigne and Rozenberg, 2002a; Ulug et al., 2004) .
In this work we aimed at reporting our experience in detail for a large series of coasted patients. Analysis of our data was done to clarify some practical points: (i) when we stopped HMG; (ii) how many days of coasting; (iii) special laboratory precautions for coasted patients.
The timing of stopping HMG and starting coasting is very important. In our study coasting was started according to the size of the leading follicles rather than the level of E 2 . When the leading follicles reached 16 mm in mean diameter, HMG was stopped. After stopping the HMG, the follicles continued to grow while the E 2 first increased and then started falling. We then waited as long as it took (2-7 days) for the E 2 to fall to 3000 pg/ml before giving HCG. Large follicles (pre-ovulatory) have the function of maximizing the diminishing circulating gonadotrophins, and they continue to enlarge despite the diminished levels of gonadotrophins (Sher et al., 1993) . If HMG is stopped earlier when the leading follicles are <16 mm in mean diameter they undergo atresia. It was demonstrated that mature follicles can survive for a few days without exoge- nous FSH/HMG, while small follicles will undergo apoptosis/ necrosis (Garcia-Velasco et al., 2004) . Gonadotrophins upregulate gonadotrophin receptors and also inhibit granulosa cell apoptosis (Chun et al., 1996) . Accordingly, during coasting, the small immature follicles, being less receptive to FSH, will undergo arrest and necrosis. It has been recently demonstrated that when coasting was started early, the percentage of mature oocytes was smaller compared with late onset of coasting (Ulug et al., 2004) . The number of days without HMG that is needed before giving HCG is variable. Different investigators withheld HMG from 2 to 9 days (Sher et al., 1993 (Sher et al., , 1995 Aboulghar et al., 2000; Al-Shawaf et al., 2001 ). 'We did not limit the duration of coasting to an arbitrary number of days. Instead, we allowed patients to coast until their E 2 reached 'safe' levels' As soon as it fell to <3000 pg/ml, HCG was given. A more sensitive method was investigated to determine when to decrease, or even stop, HMG injections (Al-Shawaf et al., 2002) by measuring E 2 and FSH levels. It was found that FSH decreased by 25% during the coasting period, and ≤5 mIU/ml was safe to trigger ovulation. Therefore reduction of circulating FSH may be the mechanism of reducing OHSS (Meldrum, 2002) , which can take from 2 to 9 days. Furthermore, it was demonstrated that the duration of coasting did not have an impact on the IVF outcome (Delvigne and Rozenberg 2002b) . It has also been demonstrated that the rate of decrease in E 2 level during coasting was not important (Ulug et al., 2004) . The authors concluded that the criteria for initiating coasting can be flexible, and once follicles passed the threshold of increasing in size, irrespective of E 2 level, coasting can be started without compromising the outcome (Ulug et al., 2004) . Similarly it has been found that the rate of E 2 decrease did not alter the pregnancy rate (Delvigne and Rozenberg, 2002b) . However, in one study (Isaza et al., 2002) , it has been suggested that if coasting required >5 days, or if an abrupt fall was observed in serum E 2 levels (<1000 pg/ml), the oocyte quality might be affected. Other studies demonstrated that prolonged coasting for >4 days reduced IVF outcome (Tortoriello et al., 1998; Izaza et al., 2002) . In our study the number of coasting days affected the ICSI outcome. When coasting was done for >3 days, the mean number of oocytes retrieved, the implantation and clinical pregnancy rates were significantly reduced. The more the days of coasting, the more pronounced the adverse effects on the results. In 80% of the coasted cases, the E 2 level fell to <3000 pg/ml in <4 days (group I). Only 20% of the cases needed ≥4 days for the E 2 level to fall to <3000 pg/ml (group II). Although the implantation and clinical pregnancy rates were significantly reduced in group II, this group of patients achieved a 36% clinical pregnancy rate, which is very acceptable. However, because safety comes first, we should not be restricted by the number of coasting days and give HCG before the E 2 level falls to <3000 pg/ml.
The OHSS cases that occurred during the 5 year period of this study were given HCG before E 2 fell to 3000 pg/ml. These cases were among the first to participate in this protocol of coasting, before we gained enough experience. It is interesting to note that there were two cases of OHSS in our centre during this time that were not diagnosed to be 'high risk' and did not undergo coasting. In both of them the E 2 level did not exceed 3000 pg/ml. This protocol of coasting was very effective in markedly reducing the incidence of severe OHSS in our centre. During the 5 year period of this study, controlled ovarian stimulation was performed in 12 494 ICSI cycles and only 16 patients developed OHSS (0.13%), and it was only 1.3% in patients who were at risk of developing OHSS. It should be noted, however, that all these 16 cases were patients with polycystic ovary syndrome (PCOS). It is well recognized that patients with PCOS are more prone to develop OHSS (Bider et al., 1989; Navot et al., 1992; Aboulghar and Mansour, 2003) . It is also important to note that all these 16 cases received HCG when the E 2 level was >3000 pg/ml (4916 ± 2704) after coasting.
In the laboratory, these coasted patients needed extra time and care. It should be noted that the OCC could not be visualized easily due to the diminished number of granulosa cells around the oocytes. It is advisable to have two embryologists working simultaneously during the oocyte retrieval procedure to identify the OCC. Otherwise no special precautions were required in the ovum retrieval technique itself.
The pathogenesis of OHSS is not fully understood. However, the condition is triggered with HCG and is associated with very high E 2 levels and a series of events that leads to increased capillary permeability and extravasations of fluid in the abdominal cavity (Rizk and Aboulghar, 1999) . There are different mediators such as elevation of plasma rennin activity (Haning et al., 1985) , proinflammatory cytokines such as interleukin-6 and interleukin 1β (Fredhlander et al., 1993) , and vascular endothelial growth factor (VEGF) (Mclure et al., 1994) . In coasting, HMG is withheld and GnRH agonist is continued until E 2 levels fall and possibly all other associated mediators will fall as well. Very recently an interesting study was published investigating the mechanism of coasting (Garcia-Velasco et al., 2004) . The authors demonstrated that the granulosa cells aspirated from coasted patients showed a ratio in favour of apoptosis, especially in smaller follicles. They also demonstrated that coasting reduces VEGF protein secretion and gene expression in granulosa cells especially in small and medium follicles. The idea of selectively inducing atresia in this follicle population without altering the delicate equilibrium with large mature follicles is the main factor in coasting (Garcia-Velasco et al., 2004) . It has been demonstrated that the small and medium-sized follicles are responsible for the high E 2 concentration and vasoreactive compounds (Al-Shawaf et al., 2001) . Recently, a new therapeutic modality was introduced through the use of LH at the end of follicular maturation (Filicori et al., 2002) . It selectively induces atresia in a small follicle population and stimulates the growth of large follicles.
In vitro maturation of oocytes (IVM) has also been proposed recently as an alternative for prevention of OHSS in patients with PCOS (Child et al., 2002) . The IVM pregnancy rate and live birth rates per retrieval were 26.2 and 15.9% compared to 38.3 and 26.2% for IVF. Compared to IVM, coasting allows in vivo maturation of the oocyte and results in a very satisfactory outcome. Why should we retrieve immature oocytes at the GV stage and mature them in vitro to reach the MII stage when we can allow complete maturation in vivo during the days of coasting, and in the mean time the E 2 level will fall to a safe level?
In conclusion, the very small incidence of OHSS in this large-sized study adds to the existing indirect evidence of the efficacy of coasting in the prevention of OHSS. The protocol used in our centre started coasting for patients at risk according to the size of the leading follicles rather than the level of E 2 . The duration of coasting was determined according to the level of E 2 to allow it to fall to a safe level. Special attention was given in the laboratory to give extra time and care for finding the OCC from coasted patients because they can be easily missed due to the diminished number of granulosa cells around the oocytes. The pregnancy rate was affected adversely as the number of coasting days increased; nevertheless, in the interests of safety it is recommended to wait until E 2 falls to <3000 pg/ml.
